FLGT News and Press, Fulgent Genetics Inc. From 12/28/21

In a meeting with some of the nation's governors, President Biden pledged to support states struggling with the Omicron variant, but acknowledged that they will need to take the lead in controlling the pandemic. Arkansas Governor Asa Hutchinson, who is chair of the National Governors Associat...

Fourth vaccine: Israel is set to become the first country in the world to administer a fourth COVID-19 vaccine, which would give "greater protection in the face of Omicron." The first eligible group to receive the vaccine will be people age 60 and older, as well as the immunocompromised and m...

Fulgent's COVID testing business isn't going away any time soon and will continue to gush cash for reinvestment, even allowing for melting ice cube scenarios. Fulgent's core business continues to grow at a high rate and has benefited from COVID testing related capitalization. Fulg...

While it's natural to track share prices of your favorite stocks, it's important to remember that price alone never indicates a good or bad stock. Shares of Fulgent Genetics (NASDAQ: FLGT) are down nearly 18% over the past week This is despite the fact that the stock reported ex...

Several assumptions are needed on the NGS segment. While management does not give much clarity to the business outside of COVID, we can still get a sense of its value. Founder-led business, with its CEO having more than 25% worth of equity on the line. I believe that at $2.5 billi...

HelioLiver can detect liver cancer in the earliest stages with a simple, non-invasive blood draw HelioLiver is now available for patients through a provider order Helio Health (“Helio”) and its commercial partner, Fulgent Genetics, Inc. (NASDAQ:...

Moats are important to any business. They're the competitive advantages that differentiate the company from its rivals. In this Motley Fool Live video recorded on Nov. 16, 2021 , Fool contributors Keith Speights and Brian Orelli answer a viewer's question about how wide the moa...

The stock market is not in the holiday spirit lately. Shares of some companies have been spiraling lower thanks to a new coronavirus mutation and the prospect of less help from the Federal Reserve. But those lower prices could be a gift to investors with a long-term outlook. That's why ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, today confirmed that the Company’s R...

Fulgent Genetics (NASDAQ: FLGT) looks poised to significantly beat its year-end investor estimates. In this Motley Fool Live video recorded on November 15 , Motley Fool contributors Keith Speights and Brian Orelli answer a viewer question about whether this means Fulgent is ...